3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
45
Carcinoma, Hepatocellular
13
Osteosarcoma
8
Neoplasms
8
Sarcoma
7
Prostatic Neoplasms
7
Neoplasm Metastasis
7
Colorectal Neoplasms
7
Sarcoma, Ewing
6
Neuroendocrine Tumors
6
Kidney Neoplasms
6
Clear-cell metastatic renal cell carcinoma
6
Carcinoma, Non-Small-Cell Lung
6
Carcinoma, Transitional Cell
4
Carcinoma, Medullary
4
Carcinoma
4
Brain Neoplasms
4
Urinary Bladder Neoplasms
3
Urethral Neoplasms
3
Thyroid Neoplasms
3
Ovarian Neoplasms
3
Melanoma
3
Endometrial Neoplasms
3
Adrenocortical Carcinoma
3
Wilms Tumor
2
Urogenital Neoplasms
2
Ureteral Neoplasms
2
Triple Negative Breast Neoplasms
2
Thyroid Cancer, Papillary
2
Stomach Neoplasms
2
Interventions
Methotrexate
6
Cyclophosphamide
6
ponatinib
5
Cytarabine
5
merphos
4
Mycophenolic Acid
4
blinatumomab
3
Whole-Body Irradiation
3
Tacrolimus
3
Peripheral Blood Stem Cell Transplantation
3
Cyclosporine
3
venetoclax
2
fludarabine phosphate
2
bosutinib
2
Vincristine
2
Rituximab
2
N,N-dicyclohexyl-isoborneol-10-sulfonamide
2
Idarubicin
2
Etoposide
2
Cladribine
2
CT-P10
2
Busulfan
2
prednylidene
1
pegfilgrastim
1
nilotinib
1
midostaurin
1
gilteritinib
1
fludarabine
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Blast Crisis
×
cabozantinib
×
1 year
×
Clear all
No trials found.